Labetalol HCl in Sodium Chloride

Hikma Pharmaceuticals USA Inc.🇺🇸 United States

FDA Page

Effective Date: Mar 1, 2022
Approval ID: 99a715a0-4579-410c-b102-7ef6fab8db55
Products: 4 registered
Version: 7

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use LABETALOL HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for LABETALOL HYDROCHLORIDE. LABETALOL HYDROCHLORIDE IN SODIUM CHLORIDE injection , for intravenous use. LABETALOL HYDROCHLORIDE IN DEXTROSE injection , for intravenous use. LABETALOL HYDROCHLORIDE injection, for intravenous use. Initial U.S. Approval: 1984

Quick Stats

Total Products4

Labelers2

Label Sections20

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.